Related Experiment Video
Updated: May 9, 2026
11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Pars plana vitrectomy for vitreomacular traction syndrome
Damir Kovacević1, Vedran Markusić
1University of Rijeka, Rijeka University Hospital Center, Department of Ophthalmology, Rijeka, Croatia. oftalmologija@kbc-rijeka.hr
Collegium Antropologicum
|July 11, 2013
Summary
Pars plana vitrectomy effectively treats vitreomacular traction syndrome (VMTS) with outcomes comparable to other vitrectomies. Future treatments may involve enzymatic vitreolysis for non-refractory VMTS cases.
Area of Science:
- Ophthalmology
- Retina Surgery
Background:
- Vitreomacular traction syndrome (VMTS) occurs due to incomplete posterior vitreous detachment causing macular traction.
- Spontaneous resolution is possible with complete posterior vitreous detachment, but vitrectomy is indicated for persistent cases (4-6 months) causing severe visual impairment.
Purpose of the Study:
- To evaluate the efficacy and safety of pars plana vitrectomy for macular disorders stemming from vitreomacular traction.
Main Methods:
- Pars plana vitrectomy was performed on patients with VMTS.
Main Results:
- Surgical outcomes and complication rates (number and severity) were similar to vitrectomies performed for other conditions.
- The study demonstrated comparable safety and efficacy of vitrectomy in VMTS.
Conclusions:
- Pars plana vitrectomy is an effective treatment for vitreomacular traction syndrome.
- The development of enzymatic vitreolysis may limit future vitrectomy use to refractory VMTS cases.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...